\
&
Contact us
\
&
Contact us
This was 4 years ago
LocationOnline only
ProgrammesThe EuroNanoForum 2021 conference will address the role of nano-enabled technologies and industries in the transformation towards EU prosperity. The event will bring forward the role of R&I, as well as the opportunities offered by EU’s next Framework Programme; Horizon Europe.
The event will bring together experts across different sectors to identify policy options and priorities. In addition to sharing insight on technical, industrial and social challenges, views and ideas will be discussed on the role of Nanotechnology and Advanced Materials on EU’s Recovery. The different solutions for boosting the economy through clean technology will be examined, highlighting their benefits and practical challenges, with regards to safety, health and environment, as well as ethical and societal issues.
More information and possibility to register on the EuroNanoForum website
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Climate, Energy, Mobility Agro-Food, Environment Missions
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
